Hellman Jordan Management Company’s Direxion Daily S&P Biotech Bull 3X ETF LABU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-1,000
Closed -$135K 54
2022
Q2
$135K Sell
1,000
-1,872
-65% -$319K 0.18% 54
2022
Q1
$900K Buy
2,872
+1,325
+86% +$500K 0.98% 42
2021
Q4
$1.11M Buy
1,547
+1,047
+209% +$1M 1.34% 35
2021
Q3
$553K Buy
+500
New +$614K 0.78% 49
2021
Q2
Sell
-2,500
Closed -$3.95M 58
2021
Q1
$3.95M Buy
2,500
+1,750
+233% +$4.1M 5.73% 2
2020
Q4
$1.51M Sell
750
-750
-50% -$1.2M 4.79% 7
2020
Q3
$1.61M Sell
1,500
-250
-14% -$287K 3.06% 11
2020
Q2
$2.08M Sell
1,750
-2,250
-56% -$1.95M 3.36% 12
2020
Q1
$1.8M Buy
4,000
+250
+7% +$227K 4.27% 9
2019
Q4
$4.31M Sell
3,750
-1,250
-25% -$1.12M 4.84% 5
2019
Q3
$3.09M Hold
5,000
2.45% 11
2019
Q2
$5.02M Buy
5,000
+750
+18% +$726K 6.85% 4
2019
Q1
$5.09M Buy
+4,250
New +$4.42M 3.55% 11
2018
Q4
Sell
-5,500
Closed -$10.2M 60
2018
Q3
$10.2M Buy
5,500
+500
+10% +$982K 7.37% 6
2018
Q2
$9.49M Sell
5,000
-1,250
-20% -$2.2M 7.61% 4
2018
Q1
$9.93M Buy
6,250
+1,750
+39% +$3.26M 16.4% 1
2017
Q4
$7.01M Hold
4,500
11.03% 3
2017
Q3
$7.69M Buy
4,500
+2,000
+80% +$2.77M 16.74% 1
2017
Q2
$3.15M Buy
+2,500
New +$2.52M 6.77% 2
2016
Q4
$6.26M Buy
10,000
+1,250
+14% +$939K 8.57% 1
2016
Q3
$5.07M Sell
8,750
-1,250
-13% -$1.03M 5.12% 3
2016
Q2
$5.64M Buy
+10,000
New +$6.26M 11.39% 2

Other funds holding LABU

Hellman Jordan Management Company's LABU Position: Q3 2022 in Review

Hellman Jordan Management Company sold out of Direxion Daily S&P Biotech Bull 3X ETF (LABU) in Q3 2022, closing a stake of 1,000 shares — an estimated $135K sold.

Hellman Jordan Management Company first reported a position in LABU in Q2 2016 and held it in 22 quarters. The position peaked at $10.2M in Q3 2018. 47 funds tracked by Wall St. Rank hold LABU as of Q3 2022.

  • Hellman Jordan Management Company reported no remaining Direxion Daily S&P Biotech Bull 3X ETF position as of Q3 2022 after selling out during the quarter.
  • Hellman Jordan Management Company sold 1,000 Direxion Daily S&P Biotech Bull 3X ETF shares in Q3 2022, an estimated $135K.
  • Hellman Jordan Management Company first reported a position in Direxion Daily S&P Biotech Bull 3X ETF in Q2 2016 and held it in 22 quarters.
  • Hellman Jordan Management Company's Direxion Daily S&P Biotech Bull 3X ETF position peaked at $10.2M in Q3 2018.
  • 47 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bull 3X ETF as of Q3 2022.

Based on Hellman Jordan Management Company's 13F filing for Q3 2022, filed 13 Oct 2022.